Lumos Diagnostics Holdings Limited (ASX:LDX) Stock Catapults 35% Though Its Price And Business Still Lag The Industry
Lumos Diagnostics Holdings Limited (ASX:LDX) shares have had a really impressive month, gaining 35% after a shaky period beforehand. But the last month did very little to improve the 54% share price decline over the last year.
Although its price has surged higher, Lumos Diagnostics Holdings may still be sending buy signals at present with its price-to-sales (or “P/S”) ratio of 1.6x, considering almost half of all companies in the Medical Equipment industry in Australia have P/S ratios greater than 3.4x and even P/S higher than 16x aren’t out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it’s justified.
